Healthtech and edtech are two of the fastest growing sectors, with the healthtech market size to reach $3.1 billion by 2033, while the global education technology market size is projected to reach ...

WEIGHT loss jabs are not an acceptable solution to obesity in Britain, says Professor Chris Whitty. England’s Chief Medical ...

The proposal has always been carried by Locke and other Democratic Black lawmakers, and Sen. Chris Head, R-Botetourt, a white male Republican, lent his bipartisan support. As a key part of the ...

Driven by high prices, lack of insurance, and a desire to lose weight, the proliferation of fake and falsified obesity drugs is prompting public health concern. Sophie Cousins reports.

Growing up with Boomer parents and grandparents meant absorbing a whole vocabulary that nobody else on the planet seemed to ...

GLP-1 weight loss drugs are trending worldwide. Doctors explain how they work, who should take them, and the benefits and risks of these metabolic medications.

In her new book, the veteran newscaster shares that her childhood friend was in a relationship with the famed artist ...

Confused about tirzepatide vs semaglutide for weight loss? Here’s a clear comparison of effectiveness, side effects, dosage, ...

In recent years, GLP-1 receptor agonists have revolutionised discussions of weight reduction and diabetes management. Type 2 ...

The family of a new dad who died at just 33-years-old from bile-duct cancer have hit out at health officials who rejected the use of a potentially life-saving treatment on the NHS .